FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov

WHBL Sheboygan

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer FDA.gov FDA expands approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood. Release. The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the ... First Tx for Erdheim-Chester Disease, a Rare Blood CancerMedscape FDA approves Roche drug for rare type of blood cancerReuters FDA approves Zelboraf for BRAF V600-mutated Erdheim-Chester diseaseHealio Newswise (press release) -Pharmacy Times -Curetoday.com -OncLive all 11 news articles »

from Health - Google News http://ift.tt/2yaDWsB